Source: Becker's Spine Review

Morgenthaler: Device maker Moximed closes on $91M funding deal

Knee implant maker Moximed has closed on a round of stock financing for up to $91 million, according to an Aug. 13 report from Mass Device.

Read full article »
Morgenthaler's Competitors | Morgenthaler's News | Morgenthaler's Financials
Stay up-to-date with the latest news on Morgenthaler
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
David T. Morgenthaler's photo - Managing Partner of Morgenthaler

Managing Partner

David T. Morgenthaler

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Morgenthaler